Concepedia

Author

Anne Rogiers

Universitair Ziekenhuis BrusselORCID

Also Known As

A Rogiers, A. Rogiers, A.I. Rogiers, ANNE ROGIERS, Anne Rogiers

61

Publications

681

Citations

13

H-Index

24

Concepts

All Affiliations

Universitair Ziekenhuis BrusselCentre Hospitalier Universitaire BrugmannVrije Universiteit BrusselUniversité Libre de BruxellesCentre Hospitalier Universitaire de Liège
AR

About

Anne Rogiers is an author at Universitair Ziekenhuis Brussel specializing in medicine, cancer therapeutics, and oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

5

5

158

2

Neurology

3

3

83

3

Health Sciences

2

2

73

4

Immunology

1

1

11

5

Pharmacology

1

1

11

Anne Rogiers

×

14

Publications

525

Citations

12

H-Index

YearCitations

Concomitant oral tyrosine kinase inhibitors and bisphosphonates in advanced renal cell carcinoma with bone metastases

Benoit Beuselinck, Pascal Wolter, Alexandra Karadimou,

British Journal of Cancer

2012

110

Health-related quality of life, emotional burden, and neurocognitive function in the first generation of metastatic melanoma survivors treated with pembrolizumab: a longitudinal pilot study

Anne Rogiers, Christophe Leys, Jennifer Cremer,

Supportive Care in Cancer

2019

62

Randomized phase II trial comparing axitinib with the combination of axitinib and lomustine in patients with recurrent glioblastoma

Johnny Duerinck, Stephanie Du Four, Frank Bouttens,

Journal of Neuro-Oncology

2017

61

Axitinib plus avelumab in the treatment of recurrent glioblastoma: a stratified, open-label, single-center phase 2 clinical trial (GliAvAx)

Gil Awada, Laïla Ben Salama, Jennifer Cremer,

Journal for ImmunoTherapy of Cancer

2020

54

Calcitonin Gene-Related Peptide8-37 Antagonizes Capsaicin-Induced Vasodilation in the Skin: Evaluation of a Human in Vivo Pharmacodynamic Model

Bart Van der Schueren, Anne Rogiers, F. H. Vanmolkot,

Journal of Pharmacology and Experimental Therapeutics

2008

47

Neurocognitive Function, Psychosocial Outcome, and Health‐Related Quality of Life of the First‐Generation Metastatic Melanoma Survivors Treated with Ipilimumab

Anne Rogiers, Christophe Leys, Justine Lauwyck,

Journal of Immunology Research

2020

39

A Comprehensive Analysis of Baseline Clinical Characteristics and Biomarkers Associated with Outcome in Advanced Melanoma Patients Treated with Pembrolizumab

Gil Awada, Yanina Jansen, Julia Katharina Schwarze,

Cancers

2021

35

Health-related quality of life of long-term advanced melanoma survivors treated with anti-CTLA-4 immune checkpoint inhibition compared to matched controls

Annelies H. Boekhout, Anne Rogiers, Katarzyna Jóźwiak,

Acta Oncologica

2020

30

Patient-reported outcomes for monitoring symptomatic toxicities in cancer patients treated with immune-checkpoint inhibitors: A Delphi study

André Manuel da Silva Lopes, Sara Colomer‐Lahiguera, Nuria Mederos Alfonso,

European Journal of Cancer

2021

24

The role of cytotoxic drugs in the treatment of central nervous system gliomas.

Bart Neyns, Miguel D’haeseleer, Anne Rogiers,

PubMed

2010

16

Page 1